Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07172178 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

γδ T-PD-1 Ab Cells in the Treatment of Malignant Meningioma

StatusNot Yet Recruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study intends to combine the advantages of γδ T cells and PD-1 monoclonal antibody to conduct an exploratory clinical study on the safety and efficacy of PD-1 antibody armored γδ T cells (γδ T-PD-1 Ab cells) in the treatment of malignant meningioma.
Trial Details
NCT Number NCT07172178
Lead Sponsor Nanjing Medical University
Conditions
(from sponsor)		 Malignant Meningioma
Related terms Meningioma
Enrollment 12 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov